Cargando…
The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model
The dense tumor stroma of pancreatic ductal adenocarcinoma (PDAC) and its secreted immune active molecules provide a barrier for chemotherapy treatment as well as for immune cell infiltration to the tumor core, providing a challenge for immunotherapeutic strategies. Consequently, the investigation o...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185841/ https://www.ncbi.nlm.nih.gov/pubmed/37205118 http://dx.doi.org/10.3389/fimmu.2023.1155085 |
_version_ | 1785042445281525760 |
---|---|
author | Geyer, Marlene Gaul, Lisa-Marie D`Agosto, Sabrina Luigia Corbo, Vincenzo Queiroz, Karla |
author_facet | Geyer, Marlene Gaul, Lisa-Marie D`Agosto, Sabrina Luigia Corbo, Vincenzo Queiroz, Karla |
author_sort | Geyer, Marlene |
collection | PubMed |
description | The dense tumor stroma of pancreatic ductal adenocarcinoma (PDAC) and its secreted immune active molecules provide a barrier for chemotherapy treatment as well as for immune cell infiltration to the tumor core, providing a challenge for immunotherapeutic strategies. Consequently, the investigation of processes underlying the interaction between the tumor stroma, particularly activated pancreatic stellate cells (PSCs), and immune cells may offer new therapeutic approaches for PDAC treatment. In this study, we established a 3D PDAC model cultured under flow, consisting of an endothelial tube, PSCs and PDAC organoids. This was applied to study the role of the tumor microenvironment (TME) on immune cell recruitment and its effect on partly preventing their interaction with pancreatic cancer cells. We observed that stromal cells form a physical barrier, partly shielding the cancer cells from migrating immune cells, as well as a biochemical microenvironment, that seems to attract and influence immune cell distribution. In addition, stromal targeting by Halofuginone led to an increase in immune cell infiltration. We propose that the here developed model setups will support the understanding of the cellular interplay influencing the recruitment and distribution of immune cells, and contribute to the identification of key players in the PDAC immunosuppressive TME as well as support the discovery of new strategies to treat this immune unresponsive tumor. |
format | Online Article Text |
id | pubmed-10185841 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101858412023-05-17 The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model Geyer, Marlene Gaul, Lisa-Marie D`Agosto, Sabrina Luigia Corbo, Vincenzo Queiroz, Karla Front Immunol Immunology The dense tumor stroma of pancreatic ductal adenocarcinoma (PDAC) and its secreted immune active molecules provide a barrier for chemotherapy treatment as well as for immune cell infiltration to the tumor core, providing a challenge for immunotherapeutic strategies. Consequently, the investigation of processes underlying the interaction between the tumor stroma, particularly activated pancreatic stellate cells (PSCs), and immune cells may offer new therapeutic approaches for PDAC treatment. In this study, we established a 3D PDAC model cultured under flow, consisting of an endothelial tube, PSCs and PDAC organoids. This was applied to study the role of the tumor microenvironment (TME) on immune cell recruitment and its effect on partly preventing their interaction with pancreatic cancer cells. We observed that stromal cells form a physical barrier, partly shielding the cancer cells from migrating immune cells, as well as a biochemical microenvironment, that seems to attract and influence immune cell distribution. In addition, stromal targeting by Halofuginone led to an increase in immune cell infiltration. We propose that the here developed model setups will support the understanding of the cellular interplay influencing the recruitment and distribution of immune cells, and contribute to the identification of key players in the PDAC immunosuppressive TME as well as support the discovery of new strategies to treat this immune unresponsive tumor. Frontiers Media S.A. 2023-05-02 /pmc/articles/PMC10185841/ /pubmed/37205118 http://dx.doi.org/10.3389/fimmu.2023.1155085 Text en Copyright © 2023 Geyer, Gaul, D`Agosto, Corbo and Queiroz https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Geyer, Marlene Gaul, Lisa-Marie D`Agosto, Sabrina Luigia Corbo, Vincenzo Queiroz, Karla The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model |
title | The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model |
title_full | The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model |
title_fullStr | The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model |
title_full_unstemmed | The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model |
title_short | The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model |
title_sort | tumor stroma influences immune cell distribution and recruitment in a pdac-on-a-chip model |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185841/ https://www.ncbi.nlm.nih.gov/pubmed/37205118 http://dx.doi.org/10.3389/fimmu.2023.1155085 |
work_keys_str_mv | AT geyermarlene thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel AT gaullisamarie thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel AT dagostosabrinaluigia thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel AT corbovincenzo thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel AT queirozkarla thetumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel AT geyermarlene tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel AT gaullisamarie tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel AT dagostosabrinaluigia tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel AT corbovincenzo tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel AT queirozkarla tumorstromainfluencesimmunecelldistributionandrecruitmentinapdaconachipmodel |